Global Home/Self Testing Market, By Product Type (Diagnostic Kits, Diagnostic Device, Diagnostic Strips), Usage (Disposable, Reusable), Sample Types (Saliva, Urine), Form Types (Cassette, Strip, Midstream, Digital Monitoring Instrument, Test Panel, Cup, Dip Card), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, Online Pharmacies), Application (Cholesterol and Triglycerides Tests, Diabetes and Glucose Tests, Others) – Industry Trends and Forecast to 2029.
Home/Self Testing Market???? Analysis and Size
Some diseases or conditions can be tested for at home using home use tests. These tests are inexpensive, quick, and private. Home use tests can be beneficial to detect possible health conditions when there are no symptoms, allowing you to receive early treatment and reduce your risk of developing later complications (i.e. cholesterol testing, hepatitis testing), detect specific conditions when there are no warning signs, allowing you to take immediate action (i.e. pregnancy testing), monitor conditions to allow for frequent treatment changes (i.e. glucose testing to monitor blood sugar levels in diabetes).
Data Bridge Market Research analyses that the home/self testing market which was USD 20.1 billion in 2021, is expected to reach USD 39.18 billion by 2029, at a CAGR of 8.70% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Home/Self Testing Market Scope and Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Million, Volumes in Units, Pricing in USD
Product Type (Diagnostic Kits, Diagnostic Device, Diagnostic Strips),Usage (Disposable, Reusable), Sample Types (Saliva, Urine), Form Types (Cassette, Strip, Midstream, Digital Monitoring Instrument, Test Panel, Cup, Dip Card), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, Online Pharmacies), Application (Cholesterol and Triglycerides Tests, Diabetes and Glucose Tests, Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
PRIMA Lab SA (Switzerland), bioLytical Laboratories Inc. (Canada), OraSure Technologies, Inc. (U.S.), Nectar Lifesciences Ltd. (India), Piramal Enterprises Ltd. (India), Cardinal Health (U.S.), Johnson & Johnson Services, Inc (U.S.), B. Braun Melsungen AG (Germany), BD (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Siemens Medical Solutions USA Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France)
A self-test enables the entire process to be carried out at home. A sample is taken at home, and the results are given on-site. The test kit includes instructions for interpreting the results. In most cases, self-tests yield results in less than an hour. A self-test is also known as a "home-test" or a "at-home test." These self-collection kits and tests are available by prescription or without a prescription in a pharmacy or retail store. For the detection of current infection, currently available self-collection kits and tests are used.
Global Home/Self Testing Market Dynamics
- Growing adoption of self-testing kits
People used to go to hospitals all the time, even for minor issues. However, as consumer awareness of various products has grown. People nowadays prefer to perform basic tests at home with test kits rather than visiting a doctor. This has become even more apparent as a result of the pandemic, as people are adopting more self-help testing kits as a result of the restrictions in place. It has proven to be disguise for both hospitals and patients, as hospitals are already overburdened and can now focus solely on COVID-19 patients, and patients can save money on doctor visits and medication. It has become extremely convenient for consumers because they can quickly learn the results of their tests. These are some of the factors which propel the growth of the market.
- Easy availability of self-testing kits at pharmacies
At-home or self-testing kits are widely available in pharmacies, and obtaining them become simple. Several medical companies are entering this market, rapidly producing self-test kits. This widespread availability can also be attributed to the medical start-ups of online pharmacies, which make availability easier by clicking a button. These self-testing kits are also available without a prescription. These all factors will boost the growth of the market.
- Advent of advanced technologies
The most recent technologies are critical in making medical products that are both advanced and trustworthy. Artificial Intelligence (AI) and Machine Learning (ML) are important aspects of the healthcare sector in various medical devices, with the ability to improve patient safety and administrative processes through work automation and faster performance. AI-powered diagnostic instruments will undoubtedly continue to evolve by default. AI has made only modest inroads into a vast and multifaceted opportunity in the healthcare sector.
- Lack of high accuracy
Incorrect result generation or lack of high accuracy will obstruct the market's growth rate. Unreliability of results led critics to believe that some home test devices cause fear and a waste of time and money because they are untrustworthy and produce false results if not performed precisely. Nonetheless, the growing desire of patients to detect potential health complications at an early stage has made home testing more popular.
This home/self testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the home/self testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Home/Self Testing Market
COVID-19 had a significant impact on the global market for home/self testing. The market for home/self testing is growing as a result of the growing popularity of self-help and Do-It-Yourself (DIY) test kits due to their ease of use and quick results. Consumers are concerned about the dependability of rapid home testing kits, which may hamper the market. Companies now urgently require COVID-19 rapid testing kits in order to reduce patient deaths and increase patient recovery rates, as well as an increased rate for the market for diabetic patients and patients with heart problems. This creates a significant market opportunity for home testing kits.
The pandemic has allowed consumers to be tested for the virus in the privacy of their own homes, a convenience that companies such as Abbott Laboratories and Quest Diagnostics are hoping will appeal to people when it comes to other diagnostics. Home testing was already on the rise around the world as consumers became more involved in their healthcare.
- In April 2021, Atomo Diagnostics and Viatris agreed to support Unitaid's efforts to increase access to HIV self-testing in low and middle-income countries (LMIC). The Unitaid expansion programme will fund the distribution of up to one million HIV self-test kits, with plans to make testing available in 135 countries. This will assist the company in expanding its global market presence.
- In October 2021, ACON Laboratories, Inc. announced that the US Food and Drug Administration had approved its Flowflex COVID-19 Antigen Home Test for emergency use. This will assist the company in expanding its product portfolio and increasing its global market presence.
Global Home/Self Testing Market Scope
The home/self testing market is segmented on the basis of product type, usage, sample types, form types, distribution channel and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Diagnostic Kits
- Diagnostic Device
- Diagnostic Strips
- Digital Monitoring Instrument
- Test Panel
- Dip Card
- Retail Pharmacies
- Drug Store
- Online Pharmacies
- Cholesterol and Triglycerides Tests
- Diabetes and Glucose Tests
Home/Self Testing Market Regional Analysis/Insights
The home/self testing market is analysed and market size insights and trends are provided by country, product type, usage, sample types, form types, distribution channel and application as referenced above.
The countries covered in the home/self testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the home/self testing market due to rising product penetration and greater patient adoptions.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing number of population suffering from covid cases
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The home/self testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for home/self testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the home/self testing market. The data is available for historic period 2010-2020.
Competitive Landscape and Home/Self Testing Market Share Analysis
The home/self testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to home/self testing market.
Some of the major players operating in the home/self testing market are:
- PRIMA Lab SA (Switzerland)
- bioLytical Laboratories Inc. (Canada)
- OraSure Technologies, Inc. (U.S.)
- Nectar Lifesciences Ltd. (India)
- Piramal Enterprises Ltd. (India)
- Cardinal Health (U.S.)
- Johnson & Johnson Services, Inc (U.S.)
- B. Braun Melsungen AG (Germany)
- BD (U.S.)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Alere Inc. (U.S.)
- Beckman Coulter, Inc. (U.S.)
- Siemens Medical Solutions USA Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- bioMérieux (France)